Similar to MYCN-amplified tumours, the common and likely initiating events in the founder clone (C0) were large-scale chromosome 10 loss and/or chromosome 17q gain, with subclonal MYC amplification occurring later during tumour evolution. Here, MYCN is linked to neoplasm.